Alliance Pharma plc (LON:APH – Get Rating)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 69.66 ($0.86) and traded as low as GBX 61.47 ($0.76). Alliance Pharma shares last traded at GBX 62.50 ($0.77), with a volume of 1,095,470 shares trading hands.
Wall Street Analyst Weigh In
Separately, Berenberg Bank dropped their target price on Alliance Pharma from GBX 110 ($1.36) to GBX 105 ($1.30) and set a “buy” rating on the stock in a research report on Tuesday, January 17th.
Alliance Pharma Trading Up 0.3 %
The company has a current ratio of 1.93, a quick ratio of 1.42 and a debt-to-equity ratio of 45.88. The company has a market capitalization of £338.58 million and a price-to-earnings ratio of 3,125.00. The company has a fifty day moving average of GBX 53.25 and a 200-day moving average of GBX 69.66.
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products.
Featured Articles
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
